Dominion Energy Inc vs IDEXX Laboratories, Inc. — how do they compare? Dominion Energy Inc trades at $68.12 (market cap $59.90B), while IDEXX Laboratories, Inc. trades at $572.03 (market cap $46.22B). The key difference: Dominion Energy Inc is the larger of the two by market cap, and Dominion Energy Inc pays a 3.92% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals.
| D | IDXX | |
|---|---|---|
Market Cap | $59.90B | $46.22B |
Sector | Utilities | Health |
52-Week High | $71.67 | $766.68 |
52-Week Low | $57.08 | $526.44 |
Enterprise Value | $114.01B | $47.12B |
Dividend Yield | 3.92% | — |
Signals from Pluang's Aura AI — not financial advice
Dominion Energy (D) trades at $67.14, down 0.38% on the day, with a bearish technical signal and neutral oscillators. The stock shows strong fundamentals with Q2 2026 EPS beating estimates at $0.79 versus $0.681 expected, and revenue growth to $16.51B in 2025. Analysts maintain a consensus price target of $70.43, with 34% buy ratings. Recent news highlights data center demand driving performance, though merger speculation with NextEra introduces uncertainty.
Outlook remains cautiously optimistic given earnings beats and dividend consistency, but risks include high debt levels and potential regulatory pressures. The stock offers steady income with a $0.67 quarterly dividend, yet investors should weigh execution risks against growth from energy infrastructure demands.
IDEXX Laboratories (IDXX) trades at $595.76, up 1.55% on the day, with a bullish technical signal and strong fundamental performance. Recent Q2 2026 earnings beat expectations with EPS of $4.27 versus $3.94 expected, driven by 9% organic revenue growth. The company raised full-year EPS guidance to $14.69–14.94, reflecting robust demand in companion animal diagnostics. Valuation ratios remain elevated with a P/E of 41.23, supported by high profitability margins including a net income margin of 25.03% and ROE of 74.21%.
Outlook is positive given consistent earnings beats, international expansion, and product innovation, but risks include premium valuation sensitivity and competitive pressures. The consensus price target of $683.33 implies 14.7% upside, with 57% of analysts rating it Buy. Investors should weigh growth durability against high multiples.
Trailing returns across standard periods
Latest headlines on both assets
Based in Richmond, Virginia, Dominion Energy is an integrated energy company with over 30 gigawatts of electric generation capacity and more than 90,000 miles of electric transmission and distribution lines. Dominion owns a liquefied natural gas export facility in Maryland and is constructing a 5.2 GW wind farm off the Virginia Beach coast.
Read more on D →Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →